In postmenopausal women after hip arthroplasty, calcitonin significantly improved clinical outcome.
In plain wordsIn women after hip replacement, calcitonin improved clinical outcome compared with calcium and vitamin D alone.
- Peptide
- Calcitonin-salmon
- Outcome
- IncreaseClinical outcome
- Study
n = 75
- Comparator
- Calcium and vitamin D alone
- Outcome group
- Bone and joint · Musculoskeletal
- Studied dose
- 200 IU twice daily in methods; 200 IU per day in results · intranasal · 12 monthsAs given in this study (human).
Source sentences
The results of this 12-month clinical trial show that 200 IU of salmon calcitonin nasal spray per day significantly improves the clinical outcome of postmenopausal elderly women following THA.
2 context sentences(design, population, supporting numbers)
In an open study, 37 women who had undergone cementless THA after accidental hip fractures were treated twice daily with 200 IU of salmon calcitonin nasal spray for 12 months.
A parallel group of 38 women with a similar clinical status in terms of hip fractures and cementless THA were treated with only one bag of 1,000 mg calcium plus 880 IU vitamin D daily through the treatment period.